Suki Raises $90M in Series C+ Led by Healthier Capital to Scale Healthcare AI Platform

Suki Secures $90 Million in Series C+ Funding

Suki, a US healthcare AI company, has raised $90 million in a Series C+ funding round led by Healthier Capital. The round was announced on October 12, 2026.

What Suki Does

Suki's ambient clinical intelligence platform automates medical documentation, coding, and revenue-cycle workflows for clinicians. Its Suki Assistant generates clinical notes from doctor-patient conversations and integrates with electronic health record systems including Epic, Oracle Health, athenahealth, and Meditech.

The company's Ask tool adds evidence-based decision support powered by Wolters Kluwer UpToDate. Beyond its clinician-facing application, Suki licenses its speech and AI technology to more than 30 health-tech partners. The platform is used by over 450 healthcare organizations.

Funding Details

• Round type: Series C+
• Amount: $90 million
• Currency: USD
• Funding date: October 12, 2026
• Lead investor: Healthier Capital

Participating Investors

• Hedosophia
• Venrock
• Healthier Capital
• Hercules Capital
• Crosslink Capital
• Flare Capital Partners
• Zoom Ventures
• Philips Ventures

Acquisition Perspective

Suki's Series C+ round brings together a mix of financial and strategic investors, including Zoom Ventures and Philips Ventures. The company's position at the intersection of ambient documentation, coding, and revenue-cycle automation gives it a broad footprint in clinical workflow software.

Its integration with major EHR platforms—Epic, Oracle Health, athenahealth, and Meditech—places Suki in the workflow of a large share of US healthcare providers. The licensing of its speech and AI technology to more than 30 health-tech partners adds a distribution channel beyond its direct clinician application, and the reported use by over 450 healthcare organizations indicates meaningful adoption scale.

For strategic acquirers in healthcare IT, EHR, or clinical documentation markets, Suki's combination of ambient AI, EHR integrations, and partner licensing represents a differentiated asset. The participation of strategic investors such as Zoom Ventures and Philips Ventures may signal interest in the platform's technology and distribution potential.

Key Takeaways

• Suki raised $90 million in a Series C+ round led by Healthier Capital.
• The company's Suki Assistant generates clinical notes from doctor-patient conversations and integrates with Epic, Oracle Health, athenahealth, and Meditech.
• Suki licenses its speech and AI technology to more than 30 health-tech partners.
• The platform is used by over 450 healthcare organizations.
• The round included participation from Hedosophia, Venrock, Hercules Capital, Crosslink Capital, Flare Capital Partners, Zoom Ventures, and Philips Ventures.